Nutritional High comments on Health Canada statement regarding cannabis derivatives

Published: 10-Jul-2015

Nutritional High International is pleased with Health Canada's statement on 8 July 2015 regarding the use and manufacture of cannabis derivatives


Nutritional High International is pleased with Health Canada's statement on 8 July 2015 regarding the use and manufacture of cannabis derivatives.

Following the Supreme Court of Canada's decision in R. versus Smith, effectively removing restrictions on the possession of cannabis derivatives, Health Canada has taken steps to issue a section 56 exemption under the Controlled Drugs and Substances Act (CDSA), allowing companies (Licensed Producers) which have obtained a license under Marihuana for Medical Purposes Regulations (MMPR), to produce and sell cannabis oil and fresh marijuana buds and leaves in addition to dried marijuana.

The exemption under CDSA sets out the basic framework which Licensed Producers must follow to provide a legal source of cannabis oil and fresh marijuana buds and leaves.

David Posner, CEO of Nutritional High, commented: 'Cannabis oil extracts and edible products are a core of the company's business and Nutritional High is pleased with the steps Health Canada is taking to regulate cannabis derivatives.'

'In the United States, Nutritional High only conducts business in the states that have implemented adequate regulatory framework and this development provides another piece of the puzzle necessary to qualify Canada as an attractive market to target for potential expansion. Nutritional High is evaluating various alternatives to capitalise on this opportunity. We expect that as the market continues to evolve, ability to produce high quality extract and edible products will be imperative to securing market leadership,' he added.

You may also like